Guardian Pharmacy Services (GRDN) Net Income towards Common Stockholders (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Net Income towards Common Stockholders data on file, last reported at $13.5 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 46.06% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.2 million (up 177.31% YoY) and the FY2025 annual result came in at $49.0 million, up 168.92% from the prior year.
• Net Income towards Common Stockholders retreated to $13.5 million in Q1 2026 per GRDN's latest filing, from $21.3 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $21.3 million in Q4 2025, with the low at -$105.8 million in Q3 2024.
• Average Net Income towards Common Stockholders over 4 years is -$87909.1, with a median of $9.6 million recorded in 2025.
• Year-over-year, Net Income towards Common Stockholders tumbled 1412.75% in 2024 and jumped 109.07% in 2025.
• Guardian Pharmacy Services' Net Income towards Common Stockholders stood at $14.6 million in 2023, then decreased by 18.67% to $11.8 million in 2024, then jumped by 79.59% to $21.3 million in 2025, then plunged by 36.31% to $13.5 million in 2026.
• Business Quant data shows GRDN's Net Income towards Common Stockholders at $13.5 million in Q1 2026, $21.3 million in Q4 2025, and $9.6 million in Q3 2025.